Merck R&D Joke

[Anonymous]

Another Merck R&D Joke. Peter Kim was the laughing stock of the industry and his spotless legacy of ineptitude continues. When will Merck get a real CEO who knows what they are doing. I hope Roger is cleaning house of all the incompetent Boobs

 

[Anonymous]

Another Merck R&D Joke. Peter Kim was the laughing stock of the industry and his spotless legacy of ineptitude continues. When will Merck get a real CEO who knows what they are doing. I hope Roger is cleaning house of all the incompetent Boobs

I agree! Start with all the marketing and business development people. They're the ones that dictate to research that an unmet medical need exists for the 'me too' drugs.

 

[Anonymous]

HaHa...right on! As an R&D scientist my manager engaged in the exercise of checking with our marketing colleagues because almost any drug idea needed their blessing before we could discuss the concept further in the therapy area let alone do much of anything at the bench. If the market was too small or couldn't be identified then they washed their hands of it and the manager would not any support exploratory effort. It always struck me that depending on existing market data to conclude that an approach that relies on a first in class compound was short sided. If an unmet medical need did exist and it takes eight years to bring a drug to market then looking backwards to last few years sales numbers ensures that only "me too" drugs will emerge. I doubt that anybody in BizDev or Marketing would ever consider the concept of a market maker because it doesn't fit their analysis model.

 

[Anonymous]

HaHa...right on! As an R&D scientist my manager engaged in the exercise of checking with our marketing colleagues because almost any drug idea needed their blessing before we could discuss the concept further in the therapy area let alone do much of anything at the bench. If the market was too small or couldn't be identified then they washed their hands of it and the manager would not any support exploratory effort. It always struck me that depending on existing market data to conclude that an approach that relies on a first in class compound was short sided. If an unmet medical need did exist and it takes eight years to bring a drug to market then looking backwards to last few years sales numbers ensures that only "me too" drugs will emerge. I doubt that anybody in BizDev or Marketing would ever consider the concept of a market maker because it doesn't fit their analysis model.[/QUOTE

Not sure why we even need marketing people.

 

[Anonymous]

HaHa...right on! As an R&D scientist my manager engaged in the exercise of checking with our marketing colleagues because almost any drug idea needed their blessing before we could discuss the concept further in the therapy area let alone do much of anything at the bench. If the market was too small or couldn't be identified then they washed their hands of it and the manager would not any support exploratory effort. It always struck me that depending on existing market data to conclude that an approach that relies on a first in class compound was short sided. If an unmet medical need did exist and it takes eight years to bring a drug to market then looking backwards to last few years sales numbers ensures that only "me too" drugs will emerge. I doubt that anybody in BizDev or Marketing would ever consider the concept of a market maker because it doesn't fit their analysis model.[/QUOTE

Not sure why we even need marketing people.

For the very reason that MRL hasn't come up with any breakthrough or best in class products. That means that it is up to marketing to help sell the stuff you do come up with.